The Expanding Benefits of GLP‑1 Medicines
Share
GLP‑1 medicines were first created to help people with type 2 diabetes control blood sugar. Over time, experts noticed these medicines also reduce appetite and help with weight loss. But recent studies show their benefits go far beyond diabetes and obesity. Today, they are improving heart, kidney, liver, joint, and even sleep health for many people.
How GLP‑1 Medicines Work
GLP‑1 medicines, like semaglutide and tirzepatide, help the body release insulin, lower the hormone glucagon, and slow stomach emptying. This leads to better blood sugar control and less hunger. Many people lose weight while using these medicines. Interestingly, some benefits appear even in people who do not lose much weight, which shows that these medicines may also work by reducing inflammation and improving how organs function.
Protecting the Heart and Kidneys
Large clinical trials have shown that GLP‑1 medicines lower the risk of major heart problems such as heart attacks and strokes. For example, in one study with over 17,000 participants, semaglutide reduced the chance of heart attack, stroke, or death from heart disease by about 20 percent. Another trial in people with kidney disease and diabetes showed fewer cases of kidney failure and slower disease progression in those taking GLP‑1 medicines. These results are so strong that health authorities now approve some GLP‑1 medicines specifically to reduce heart and kidney risks.
Helping the Liver
Many people with obesity also develop metabolic liver problems. In a long‑term study, semaglutide helped reduce liver inflammation and scarring in people with a condition called metabolic dysfunction associated steatohepatitis, or MASH. Other new medicines, like survodutide and tirzepatide, are also showing promise in improving liver health.
Easing Joint Pain
Carrying extra weight puts strain on joints, especially the knees. In a trial with people who had obesity and knee osteoarthritis, those taking semaglutide reported much less knee pain compared to those on placebo. They also lost more weight, which likely helped reduce pressure on their joints.
Improving Sleep
Obstructive sleep apnea is a condition where breathing repeatedly stops during sleep, often linked to obesity. In recent trials, tirzepatide significantly reduced the number of breathing interruptions in adults with sleep apnea. This improvement was seen both in people using breathing devices and those who were not.
Supporting Better Mobility
For people with peripheral artery disease, walking can be painful due to poor blood flow. A study found that people taking semaglutide could walk longer distances after one year compared to those who did not take the medicine. Even a modest weight loss appeared to help blood flow and reduce leg pain.
Why These Medicines Help
Researchers believe GLP‑1 medicines reduce inflammation throughout the body. This can improve how the heart, kidneys, liver, and other organs work. While weight loss plays a big role in many benefits, it is not the only factor. These medicines also seem to directly improve how cells handle energy and reduce harmful substances in the blood.
Looking Ahead
Scientists are now exploring other uses for GLP‑1 medicines, such as treating memory problems like Alzheimer’s disease and even some mental health conditions. It will take time to understand the best doses and who will benefit most, but early research is very promising. These discoveries could mean that GLP‑1 medicines may help many more people in the future, even those who do not need to lose weight.